261 results on '"Medina, Julio C."'
Search Results
2. A Novel Maintenance Therapeutic for Opioid Use Disorder
3. Selective, Covalent Modification of β -Tubulin Residue Cys-239 by T138067, an Antitumor Agent with in vivo Efficacy against Multidrug-Resistant Tumors
4. Novel series of tunable µOR modulators with enhanced brain penetration for the treatment of opioid use disorder, pain and neuropsychiatric indications
5. EPD1504: a novel μ-opioid receptor partial agonist attenuates obsessive–compulsive disorder (OCD)-like behaviors
6. Antagonists of CXCR3: a review of current progress
7. Ferrocene as the Central Unit in Novel, Redox-Sensitive Ligands, Monomers, and Receptors
8. An Inhibitory Metabolite Leads to Dose- and Time-Dependent Pharmacokinetics of (R)-N-{1-[3-(4-Ethoxy-phenyl)-4-oxo-3,4-dihydro-pyrido[2,3-d ]pyrimidin-2-yl]-ethyl}-N-pyridin-3-yl-methyl-2-(4-trifluoromethoxy-phenyl)-acetamide (AMG 487) in Human Subjects After Multiple Dosing
9. Chapter 5 - GPR40 (FFAR1) Modulators
10. Endogenous µ‐opioid receptor activity in the lateral and capsular subdivisions of the right central nucleus of the amygdala prevents chronic postoperative pain
11. PGD2 Antagonists
12. GPR40 (FFAR1) Modulators
13. Role of LXRs in control of lipogenesis
14. Selective, covalent modification of beta-tubulin residue Cys-239 by T138067, an antitumor agent with in vivo efficacy against multidrug-resistant tumors
15. Antagonism of chemokine receptor CXCR3 inhibits osteosarcoma metastasis to lungs
16. CXCR3 Antagonists
17. Neutral molecule receptor systems using ferrocene's 'atomic ball bearing' character as the flexible element
18. Endogenous µ‐opioid receptor activity in the lateral and capsular subdivisions of the right central nucleus of the amygdala prevents chronic postoperative pain.
19. Ferrocenyl iron as a donor group for complexed silver in ferrocenyldimethyl(2.2)cryptand: a redox-switched receptor effective in water
20. Discovery and in Vivo Evaluation of Macrocyclic Mcl-1 Inhibitors Featuring an α-Hydroxy Phenylacetic Acid Pharmacophore or Bioisostere
21. Discovery of a Potent Steroidal Glucocorticoid Receptor Antagonist with Enhanced Selectivity against the Progesterone and Androgen Receptors (OP-3633)
22. Cerebrolysin improves peripheral inflammatory pain: Sex differences in two models of acute and chronic mechanical hypersensitivity
23. Molecular Characterization of Carbapenem-Resistant Acinetobacter baumannii in the Intensive Care Unit of Uruguay's University Hospital Identifies the First rmtC Gene in the Species
24. Discovery of a Potent and Selective Steroidal Glucocorticoid Receptor Antagonist (ORIC-101)
25. Discovery of the imidazole-derived GPR40 agonist AM-3189
26. Novel halogenated sulfonamides inhibit the growth of multidrug resistant MCF-7/ADR cancer cells
27. Synthesis and SAR study of potent and selective PI3Kδ inhibitors
28. Optimization beyond AMG 232: Discovery and SAR of sulfonamides on a piperidinone scaffold as potent inhibitors of the MDM2-p53 protein–protein interaction
29. Solving time-dependent CYP3A4 inhibition for a series of indole-phenylacetic acid dual antagonists of the PGD2 receptors CRTH2 and DP
30. Structure-assisted discovery of the first non-retinoid ligands for Retinol-Binding Protein 4
31. Discovery and optimization of 5-(2-((1-(phenylsulfonyl)-1,2,3,4-tetrahydroquinolin-7-yl)oxy)pyridin-4-yl)-1,2,4-oxadiazoles as novel gpr119 agonists
32. Discovery and optimization of N-(3-(1,3-dioxo-2,3-dihydro-1H-pyrrolo[3,4-c]pyridin-4-yloxy)phenyl)benzenesulfonamides as novel GPR119 agonists
33. Discovery and optimization of arylsulfonyl 3-(pyridin-2-yloxy)anilines as novel GPR119 agonists
34. Discovery and in Vivo Evaluation of the Potent and Selective PI3Kδ Inhibitors 2-((1S)-1-((6-Amino-5-cyano-4-pyrimidinyl)amino)ethyl)-6-fluoro-N-methyl-3-(2-pyridinyl)-4-quinolinecarboxamide (AM-0687) and 2-((1S)-1-((6-Amino-5-cyano-4-pyrimidinyl)amino)ethyl)-5-fluoro-N-methyl-3-(2-pyridinyl)-4-quinolinecarboxamide (AM-1430)
35. 5-Alkyl-2-urea-Substituted Pyridines: Identification of Efficacious Glucokinase Activators with Improved Properties
36. Novel Series of Potent Glucokinase Activators Leading to the Discovery of AM-2394
37. Discovery of a Potent and Selective Steroidal Glucocorticoid Receptor Antagonist (ORIC-101).
38. Phenylalanine derivatives as GPR142 agonists for the treatment of Type II diabetes
39. Discovery and optimization of a novel series of GPR142 agonists for the treatment of type 2 diabetes mellitus
40. Optimization of phenylacetic acid derivatives for balanced CRTH2 and DP dual antagonists
41. AMG 837: A potent, orally bioavailable GPR40 agonist
42. Optimization of phenylacetic acid derivatives for CRTH2 and DP selective antagonism
43. Discovery of potent and specific CXCR3 antagonists
44. Discovery, Optimization, and in Vivo Evaluation of Benzimidazole Derivatives AM-8508 and AM-9635 as Potent and Selective PI3Kδ Inhibitors
45. Abstract 3663: Discovery of sulfonamide-piperidinones as potent inhibitors of the MDM2-p53 protein-protein interaction
46. Validación de la punción aspiración con aguja fina (PAAF) en el diagnóstico de linfadenitis tuberculosa en pacientes con infección por el virus de la inmunodeficiencia humana (VIH)
47. Optimization of triazoles as novel and potent nonphlorizin SGLT2 inhibitors
48. Identification of piperazine-bisamide GHSR antagonists for the treatment of obesity
49. Antagonists of CXCR3: a review of current progress
50. Discovery of AM-7209, a Potent and Selective 4-Amidobenzoic Acid Inhibitor of the MDM2–p53 Interaction
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.